Hyperion Defi (HYPD) Share-based Compensation (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Share-based Compensation of $80880.0 for Q1 2026, down 71.08% year-over-year from $279628.0 in Q1 2025, and down 86.9% quarter-over-quarter from $617219.0 in Q4 2025.
Hyperion Defi (HYPD) Share-based Compensation (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Share-based Compensation for 10 consecutive years, with $80880.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 71.08% year-over-year to $80880.0; the TTM figure through Mar 2026 stood at $1.6 million (down 22.23% YoY), while the FY2025 annual figure was $5.8 million, up 239.47% from the prior year.
- Share-based Compensation eased to $80880.0 in Q1 2026 per HYPD's latest filing, from $617219.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.4 million in Q2 2024 and bottomed at $80880.0 in Q1 2026.
- Historically, Share-based Compensation has averaged $781759.4 across 5 years, with a median of $615094.0 in 2023.
- Annual changes were most pronounced in 2024 — Share-based Compensation soared 377.79% — and 2026, when it tumbled 71.08%.
- Hyperion Defi's Share-based Compensation stood at $890718.0 in 2022, then slumped by 35.76% to $572225.0 in 2023, then jumped by 121.5% to $1.3 million in 2024, then slumped by 51.3% to $617219.0 in 2025, then plunged by 86.9% to $80880.0 in 2026.
- Business Quant data shows HYPD's Share-based Compensation at $80880.0 in Q1 2026, $617219.0 in Q4 2025, and $279628.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | - |
| 10 | Hyperion Defi | 47.48 Mn | 37.84 Mn | 357,693.00 | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 80,880.00 |
| Mar 31, 2026 | 80,880.00 |
| Dec 31, 2025 | 617,219.00 |
| Dec 31, 2025 | 617,219.00 |
| Mar 31, 2025 | 279,628.00 |
| Mar 31, 2025 | 279,628.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 546,232.00 |
| Mar 31, 2024 | 546,232.00 |
| Dec 31, 2023 | 572,225.00 |
| Dec 31, 2023 | 572,225.00 |
| Sep 30, 2023 | 612,969.00 |
| Sep 30, 2023 | 612,969.00 |
| Jun 30, 2023 | 493,632.00 |
| Jun 30, 2023 | 493,632.00 |